INTERNATIONAL CONGRESS OF
CancerGenetics
برنامه سخنرانی ها
Personalized medicine in cancer Panel
2025/10/23
08:00-08:30 | Wellcome Massage of the Chairman of Cancer Genetics Congress
Prof. Mohammad Reza Noori Daloii |
Speaker
Position of Speaker
Distinguished Professor of Medical Genetics. Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Contact
Email: Prof.MohammadRezaNooriDaloii [at] icgcongress [dot] com
08:30-08:45 | Wellcome Message Of The Chairman Of The Personalized Medicine in Cancer Panel
Dr. Reza Shirkoohi |
Chairman
Position of Speaker
Cancer Biology Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Contact
Email: RezaShirkoohi [at] icgcongress [dot] com
08:45-09:15 | Personalized Medicine In Cancer. Past . Present And Future. An Expeience From Cancer Institute Of Iran
Dr. Reza Shirkoohi |
Speaker
Position of Speaker
Cancer Biology Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Contact
Email: RezaShirkoohi [at] icgcongress [dot] com
09:15-09:45 | Application Of Tumor Molecular Profiling In Diagnosis And Treatments Of Gynecological Cancers
Dr. Gholamreza Rafiei |
Speaker
Position of Speaker
Genome medical genetics laboratory Director
Contact
Email: GholamrezaRafiei [at] icgcongress [dot] com
09:45-10:15 | From Variants To Decisions : AI-Driven Interpretation In Precision Medicine
Dr. Farideh Ghanbari Mardasi |
Speaker
Position of Speaker
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Contact
Email: FaridehGhanbariMardasi [at] icgcongress [dot] com
10:15-10:45 | The Role Of Circulating Tumor Cells In Precision Oncology
Dr. Mohammad Reza Eskandarion |
Speaker
Position of Speaker
Cancer Research Center, Cancer Institute, IKHC, Tehran University of Medical Sciences, Tehran, Iran
Contact
Email: MohammadRezaEskandarion [at] icgcongress [dot] com
10:45-11:15 | Precision Medicine In Breast Cancer
Dr. Keivan Majidzadeh |
Speaker
Position of Speaker
Cancer Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR
Contact
Email: KeivanMajidzadeh [at] icgcongress [dot] com
The role of the microbiome in cancer Panel
2025/10/23
11:15-11:45 | Gut Microbiome in Neuro-Oncology: Emerging Roles in Glioma Progression and Therapeutic Prospects
Dr. Mohammad Saremi |
Speaker
Position of Speaker
Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Contact
Email: MohammadSaremi [at] icgcongress [dot] com
11:45-12:15 | H. pylori & Microbiome interaction in Gastric Cancer
Dr. Sara Kadkhodaei |
Speaker
Position of Speaker
Contact
Email: SaraKadkhodaei [at] icgcongress [dot] com
Regenerative and Personalized Medicine Panel Panel
2025/10/24
08:00-08:15 | Wellcome Message Of The Chairman Of The Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN) Panel
Dr. Zohreh Salatanatpouri |
Chairman
Position of Speaker
Contact
Email: ZohrehSalatanatpouri [at] icgcongress [dot] com
08:15-08:45 | Plasma-Drived Regenerative Medicine Focused Personalized Products In Wound Treatments After Cancer Surgery And Radiotherapy
Dr. Hamidreza Rahimi |
Speaker
Position of Speaker
Contact
Email: HamidrezaRahimi [at] icgcongress [dot] com
08:45-09:15 | Methylation-Based Personalized Medicine In Human Cancer
Dr. Fatemeh Khatami |
Speaker
Position of Speaker
Contact
Email: FatemehKhatami [at] icgcongress [dot] com
09:15-09:45 | Reprogramming the Tumor Battlefield: A Triple-Hit Immunoepigenetic Strategy Against Tumor Resistance”
Dr. Mohammadali Zolfaghari |
Speaker
Position of Speaker
Contact
Email: MohammadaliZolfaghari [at] icgcongress [dot] com
09:45-10:15 | Application of percision Medicine In Biomarker Prediction For Diabetic Breast Cancer Patients
Dr. Yasaman Naeimzadeh |
Speaker
Position of Speaker
Contact
Email: YasamanNaeimzadeh [at] icgcongress [dot] com
10:15-10:45 | Isolation And Characterization Of Amniotic Fluid Stem Cells And Its Anti Tumor Effect Application On Ovarian Cancer Cell Line
Dr. Shiva Gholizadeh |
Speaker
Position of Speaker
Contact
Email: ShivaGholizadeh [at] icgcongress [dot] com
Carcinogenic Viruses Panel
2025/10/24
10:45-11:00 | Wellcome Message Of The Chairman Of The Carcinogenic Viruses Panel
Dr. Seyed Reza Mohebbi |
Chairman
Position of Speaker
Contact
Email: SeyedRezaMohebbi [at] icgcongress [dot] com
11:00-11:30 | Viral Hepatitis and Liver Cancer ; Reviewing Molecular Mechanisms Of Hepatocarcinogenesis and Novel Treatments
Dr. Seyed Reza Mohebbi |
Speaker
Position of Speaker
Contact
Email: SeyedRezaMohebbi [at] icgcongress [dot] com
11:30-12:00 | How Oncoviruses Evade Host Immunity to Promote Carcinogenesis
Dr. Shahrzad Shoraka |
Speaker
Position of Speaker
Contact
Email: ShahrzadShoraka [at] icgcongress [dot] com
12:00-12:30 | Reawakening Ancient Viruses : The Role Of HERVs In Tumor Oncogenesis
Dr. Rahim Soleimani Jelodar |
Speaker
Position of Speaker
Contact
Email: RahimSoleimaniJelodar [at] icgcongress [dot] com
Metabolic Interactions in Cancer Panel
2025/10/25
08:00-08:30 | Gas Chromatography-Mass Spectrometry-Based Uuntargeted Metabolomics Reveals Metabolic Perturbations In Medullary Thyroid Carcinoma
Dr. Morteza Ghazanfari |
Speaker
Position of Speaker
pasteur institute of Iran
Contact
Email: MortezaGhazanfari [at] icgcongress [dot] com
08:30-09:00 | Metabolomics In Cancer Research
Dr. Saman Aminzadeh |
Speaker
Position of Speaker
A.Metabolomics Lab, Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran B.Department of Immunology, Pasteur Institute of Iran,Tehran, Iran
Contact
Email: SamanAminzadeh [at] icgcongress [dot] com
Genomic Variations and Cancer Management Panel
2025/10/25
09:00-09:15 | Wellcome Message Of The Chairman Of The Genomic Variations and Cancer Management Panel
Dr. Mohammadamin Tabatabaeifar |
Chairman
Position of Speaker
Position: -Professor of Medical Genetics, Department of Genetics, Isfahan University of Medical Sciences, Isfahan, Iran - The coordinator of the Harmonic Lab Network, Iran - The member of the Board of Directors, Iranian Society of Medical Genetics
Contact
Email: MohammadaminTabatabaeifar [at] icgcongress [dot] com
09:15-09:45 | The Role Of Genetic Variants In The Management Of Lynch Syndrome
Dr. Mehrdad Zeinalian |
Speaker
Position of Speaker
Isfahan University of Medical Sciences
Contact
Email: MehrdadZeinalian [at] icgcongress [dot] com
09:45-10:15 | Interaction Of HPV Infection with The Human Variome : Lessons From Epidermodysplasia Verruciformis
Dr. Sajjad Biglari |
Speaker
Position of Speaker
Farin Genetics Laboratory, Tehran, Iran
Contact
Email: SajjadBiglari [at] icgcongress [dot] com
10:15-10:45 | The Emerging Role of AI In The Management Of Cancer : Focus On Variant Data Interpretation And Integration
Dr. Mohammadamin Tabatabaeifar |
Speaker
Position of Speaker
Professor of Medical Genetics, Department of Genetics, Isfahan University of Medical Sciences, Isfahan, Iran -The coordinator of the Harmonic Lab Network, Iran - The member of the Board of Directors, Iranian Society of Medical Genetics
Contact
Email: MohammadaminTabatabaeifar [at] icgcongress [dot] com
10:45-11:15 | Hereditary Polyposis Syndromes
Dr. Massih Bahar |
Speaker
Position of Speaker
Familial and Hereditary Cancers Institute
Contact
Email: MassihBahar [at] icgcongress [dot] com
11:15-11:45 | Liquid Biopsy Followed By Variant Identification : Emerging Role In Cancer Management
Dr. Mohammad Mehdi Jahani |
Speaker
Position of Speaker
Lab director of Harmonic Medical Genetics and Pathobiology Laboratory
Contact
Email: MohammadMehdiJahani [at] icgcongress [dot] com
11:45-12:15 | The Role Of Genetic Variants In Response And Resistance To Novel Cellular Therapies : From Leukemia Genomics To The Optimization Of CAR-T Therapy
Dr. Majid Mojarrad |
Speaker
Position of Speaker
-Associate professor of Medical Genetics,MUMS -Head of Genetic Foundation of khorasan Razavi -CEO of Simbiolab Company
Contact
Email: MajidMojarrad [at] icgcongress [dot] com
Oral presentations
A Network Pharmacology Investigation into the Multi-Target Mechanisms of Withalongolide A Against Pancreatic Cancer
Panel: Bioinformatics in Cancer
Advancements of Adenovirus-Based Gene Therapy in Colorectal Cancer
Panel: Personalized medicine in cancer
Artificial Intelligence-Based Epigenetic Models for Predicting Hereditary Cancer Susceptibility
Panel: Regenerative and Personalized Medicine Panel
Cancer Incidence and Mortality in Different Populations: The Role of Genetic Ancestry
Panel: Genomic Variations and Cancer Management
Clinical Relevance of CYP3A4 Polymorphisms rs2242480 and rs55951658 as Predictive Biomarkers in Breast Cancer Risk Assessment
Panel: Genomic Variations and Cancer Management
Comprehensive Review and Meta-Analysis of Next-Generation Sequencing Applications in Lung Cancer: Focus on Mutation Identification
Panel: Bioinformatics in Cancer
Crossing the Blood–Brain Barrier Twice: Network Pharmacology and Bioinformatic Insights into Sertraline–Lomustine Synergy in Glioblastoma
Panel: Bioinformatics in Cancer
Decoding Retinoblastoma: Genetic and Epigenetic Foundations and Their Implications for Targeted Therapy
Panel: Regenerative and Personalized Medicine Panel
Discovery of Lung Cancer Biomarkers via Bioinformatics: Focus on the CAV1 Gene
Panel: Bioinformatics in Cancer
Dual-Target CAR-T Cell Strategies for Glioblastoma: Overcoming Antigen Heterogeneity and Microenvironmental Barriers
Panel: Personalized medicine in cancer
Effects of Anticancer Activity of Interferon Gamma on Colon Cancer Cell Lines: based on Network Pharmacology Analysis
Panel: Bioinformatics in Cancer
Epigenetics in Breast Cancer: From Molecular Mechanisms to Novel Therapeutic Approaches
Panel: Regenerative and Personalized Medicine Panel
Evaluation of Common Polymorphisms in Brain Cancer and Assessment of Adverse Effects of Anticancer Drugs
Panel: Bioinformatics in Cancer
From Bench to Bedside: The Clinical Translation Gap in Cancer Nanomedicine
Panel: Metabolic Interactions in Cancer
From Liquid Biopsy to Therapy: The Rising Role of Circulating Tumor Cell Clusters in Cancer Progression
Panel: Metabolic Interactions in Cancer
Glioblastoma therapy enabled by magnetic nanocomplexes; Apoptosis signaling pathway analysis
Panel: Personalized medicine in cancer
Global and Regional DNA methylation of MMP2 and expression of DNA Methyltransferase in gastric adenocarcinoma
Panel: Regenerative and Personalized Medicine Panel
Gut Microbiome Influence on Gliomas and Their Impact on Tumor Immunity and Therapy
Panel: The role of the microbiome in cancer
Harnessing Oncolytic Viruses for Targeted Treatment of Triple-Negative Breast Cancer: Promises and Challenges
Panel: The role of the microbiome in cancer
Hub microRNAs as Master Regulators in a Saffron-Targeted Breast Cancer Network
Panel: Bioinformatics in Cancer
Integrated Bioinformatics Analysis Identifies CDCA7 and DLGAP5 as Key Genes with NEAT1-Mediated lncRNA Regulation in Chronic-Phase CML
Panel: Bioinformatics in Cancer
Integrative Bioinformatics Analysis Identifies FYN and Its lncRNA–miRNA Network as Prognostic Biomarkers in Acute Myeloid Leukemia
Panel: Bioinformatics in Cancer
Integrative Bioinformatics to Identify Cell Cycle-Related Prognostic Biomarkers in Triple-Negative Breast Cancer
Panel: Bioinformatics in Cancer
Integrative Multi-Omics Analysis for Personalized Cancer Therapy Combining genomics, proteomics, and metabolomics data from CPTAC or TARGET to design individualized treatments. - Bioinformatic A...
Panel: Metabolic Interactions in Cancer
Investigating hsa-miR-193-3p and hsa-let-7e-3p and Their Target Genes IGFBP5 and AGPAT5 Associated with Fusobacterium nucleatum in Patients with Colorectal Polyps and CRC: In Silico Predictions and Experimental Validation
Panel: The role of the microbiome in cancer
Investigation of Common Genetic Variants Involved in Breast Cancer and the Interacting Roles of MicroRNAs and Obesity in Disease Pathogenesis
Panel: Regenerative and Personalized Medicine Panel
Investigation of somatic mutations and polymorphisms of the KRAS and NRAS genes in colorectal cancer.'
Panel: Genomic Variations and Cancer Management
Leveraging tumor microenvironment metabolism for smart drug delivery systems
Panel: Metabolic Interactions in Cancer
Multiscale Bioinformatic Modeling for CRISPR-Based Immune Cell Engineering: A Framework for Targeted Cancer Immunotherapy
Panel: Personalized medicine in cancer
Physiological Alterations and Gene Regulation in the Tumor Microenvironment
Panel: Regenerative and Personalized Medicine Panel
Prognostic Circulatory Non-coding RNAs and Their Potential Targets in Human Breast Cancer
Panel: Bioinformatics in Cancer
Role of Counseling and Psychological Support in Improving Fertility among Cancer Patients: A Review Study
Panel: Genomic Variations and Cancer Management
Saffron Bioactives as Adjuvant Modulators of Breast-Cancer microRNA Networks
Panel: Regenerative and Personalized Medicine Panel
Systems Biology Approach Reveals ESR1 and CDK1 Regulatory Axis with miRNA–lncRNA Network as Novel Biomarkers in Uterine Corpus Endometrial Carcinoma
Panel: Bioinformatics in Cancer
The interaction of lncRNA and mRNA in Esophageal Squamous Cell Carcinoma
Panel: Bioinformatics in Cancer
The microbiome and its role in the development of breast cancer
Panel: The role of the microbiome in cancer
The Oncobiome in Precision Cancer Care: Microbiome-Guided Diet and Personalized Therapeutics
Panel: The role of the microbiome in cancer
The role of AI in the diagnostic and treatment of the most common cancers with epigenetic roots: surveying its effectiveness in Iranian patients
Panel: Regenerative and Personalized Medicine Panel
The Role of the Microbiome in Cancer Prevention and Therapy
Panel: The role of the microbiome in cancer
The Tumor Microenvironment and Immunotherapy Response: Challenges and Opportunities in Precision Oncology
Panel: Personalized medicine in cancer
The utility of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in the early detection of postsurgical bacterial meningitis: A retrospective analysis
Panel: The role of the microbiome in cancer
Title: High-grade leiomyosarcoma with constitutional homozygous PTEN p.Pro95Arg and tumor APC/NBN VUS on paired WES
Panel: Genomic Variations and Cancer Management
Unlocking Nature's Arsenal: The Expanding Therapeutic Role of Berberine in Combating Lung Cancer
Panel: Regenerative and Personalized Medicine Panel
Unveiling Molecular Mechanisms and Biomarkers for Colitis-Associated Colorectal Cancer in Ulcerative Colitis
Panel: Bioinformatics in Cancer
Poster presentations
A Focused Review of Bioinformatics Pipelines for Circulating Tumor DNA (ctDNA) Analysis
Panel: Bioinformatics in Cancer
A Review of Genetic and Epigenetic Alterations Underlying Hereditary and Sporadic Cancer Susceptibility
Panel: Bioinformatics in Cancer
A Review on the Design of Revolutionary Synthetic Gene Circuits for Precision Gene Editing in Oncology and Cellular Reprogramming
Panel: Bioinformatics in Cancer
Advancements of Adenovirus-Based Gene Therapy in Colorectal Cancer
Panel: Bioinformatics in Cancer
Aerobic Glycolysis Gene Overexpression and Prognostic Value in Pancreatic Ductal Adenocarcinoma: A Systematic Review
Panel: Bioinformatics in Cancer
AKT1 as a central hub gene in miR-424/503 cluster-regulated oncogenic networks in cervical cancer
Panel: Bioinformatics in Cancer
An Exploratory Transcriptomic Analysis of Granulosa Cells in Normal-Weight PCOS Women Suggests Altered DNA Repair and Signaling Pathways Linked to Cancer Risk
Panel: Bioinformatics in Cancer
Application of bioinformatics tools for the detection of germline BRCA1/BRCA2 variants in diagnostic NGS data: A Systematic Review
Panel: Bioinformatics in Cancer
Application of Gene Editing Technologies in the Treatment of Colorectal Cancer: A Novel Approach in Personalized Medicine
Panel: Bioinformatics in Cancer
Artificial Intelligence-Based Epigenetic Models for Predicting Hereditary Cancer Susceptibility
Panel: Bioinformatics in Cancer
Association Between Fluoroquinolone Antibiotic Exposure and Breast Cancer Risk or Progression: A Systematic Review
Panel: Bioinformatics in Cancer
Base Editing Approaches for Correcting TP53 and KRAS Mutations in Colorectal Cancer: A Systematic Review
Panel: Bioinformatics in Cancer
Bioinformatics Analysis Identifies Shared lncRNAs Associated with CDH5 and PTPRB in the Adherens Junction Pathway of Lung Adenocarcinoma
Panel: Bioinformatics in Cancer
Bioinformatics in Oncology: Tools, Challenges, and Clinical Applications
Panel: Bioinformatics in Cancer
BRCA 1/2 mutation and incidence of skin cancers: A Systematic Review and Meta-Analysis
Panel: Bioinformatics in Cancer
Breast cancer metastasis development and the role of oncobiosis and bacterial metabolite signaling
Panel: Bioinformatics in Cancer
Can Multimodal Deep Learning Reveal Resistance Mechanisms and Improve Osimertinib Response Prediction in NSCLC?
Panel: Bioinformatics in Cancer
Chitosan-Functionalized Niosomes as a Dual-Action Delivery System for Spirulina maxima: Targeting Drug-Resistant Bacteria and Colorectal Cancer Cells
Panel: Bioinformatics in Cancer
Clinical Relevance of CYP3A4 Polymorphisms rs2242480 and rs55951658 as Predictive Biomarkers in Breast Cancer Risk Assessment
Panel: Bioinformatics in Cancer
Comprehensive Bioinformatics Analysis Identifies INHBA and Its lncRNA Network as Key Drivers of Colorectal Cancer
Panel: Bioinformatics in Cancer
Comprehensive Review and Meta-Analysis of Next-Generation Sequencing Applications in Lung Cancer: Focus on Mutation Identification
Panel: Bioinformatics in Cancer
CRISPR Models for Gene Knockout in Transcription-Coupled Repair and DNA-Protein Crosslink Outcomes in Lymphoid Leukemia
Panel: Bioinformatics in Cancer
CRISPR-Cas9 as a Therapeutic Strategy Against Oncogenic Viruses: Targeting HPV and EBV
Panel: Bioinformatics in Cancer
CRISPR-miRNA Synergy: Editing Tumor Suppressor miRNAs into Oncogenic "Dead Zones"
Panel: Bioinformatics in Cancer
Crossing the Blood–Brain Barrier Twice: Network Pharmacology and Bioinformatic Insights into Sertraline–Lomustine Synergy in Glioblastoma
Panel: Bioinformatics in Cancer
Design and Computational Analysis of CRISPR-Based Base Editors: Predicting Efficiency and Protein Stability for Precision Gene Editing
Panel: Bioinformatics in Cancer
Dietary Fiber and Gut Microbiota in Colorectal Cancer: A Narrative Review
Panel: Bioinformatics in Cancer
Dual Targeting of CD73/EGFR Axis via siRNA Nanocarriers: A Novel Immunotherapeutic Strategy Against Breast Cancer
Panel: Bioinformatics in Cancer
Dual-Target CAR-T Cell Strategies for Glioblastoma: Overcoming Antigen Heterogeneity and Microenvironmental Barriers
Panel: Bioinformatics in Cancer
Effects of Anticancer Activity of Interferon Gamma on Colon Cancer Cell Lines: based on Network Pharmacology Analysis
Panel: Bioinformatics in Cancer
Engineered exosomes in cancer gene therapy
Panel: Bioinformatics in Cancer
Engineering and Production of a Recombinant HER3-Binding Affibody-EGFP Fusion Protein as a Potential Diagnostic Probe for Cancer Research
Panel: Bioinformatics in Cancer
Engineering the Gut Microbiome for Targeted Cancer Therapies
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Hereditary Cancers: Diagnostic, Prognostic, and Therapeutic Insights
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Hereditary Cancers: Implications for Precision Oncology
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Hereditary Cancers: Mechanisms, Biomarkers, and Therapeutic Advances
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Lymphoid Leukemia: The Role of DNA Methylation, Histone Modifications, and lncRNAs
Panel: Bioinformatics in Cancer
Epigenetic Links Between Chronic Stress, Emotional Regulation, and Molecular Pathways in Hereditary Breast Cancer: Novel Perspectives for Therapy and Prevention
Panel: Bioinformatics in Cancer
Epigenetic Memory in Hereditary Cancers: Bridging Germline Mutations, Somatic Evolution, and Synthetic Therapeutic Vulnerabilities
Panel: Bioinformatics in Cancer
Epigenetic Reactivation of Fetal Hemoglobin in Leukemia: A Mechanism of Clonal Advantage
Panel: Bioinformatics in Cancer
Epigenetic Regulation and Therapeutic Implications in Hereditary Cancers
Panel: Bioinformatics in Cancer
Epigenetic Regulation of EBV Reactivation in Immunocompromised Patients
Panel: Bioinformatics in Cancer
Epigenetic Therapies Against Virus-Driven Cancers: A New Frontier
Panel: Bioinformatics in Cancer
Epigenetics in Breast Cancer: From Molecular Mechanisms to Novel Therapeutic Approaches
Panel: Bioinformatics in Cancer
EV-Mediated Immune Modulation in Tumor Microenvironment
Panel: Bioinformatics in Cancer
Evaluation of Common Polymorphisms in Brain Cancer and Assessment of Adverse Effects of Anticancer Drugs
Panel: Bioinformatics in Cancer
Evaluation of miR-98-5P and GAB2 gene expression in endometriosis
Panel: Bioinformatics in Cancer
Examination Binding and Specificity of New Luciferase-Affiprobe to Breast Cancer Cells
Panel: Bioinformatics in Cancer
Exosomal microRNAs as a therapeutic approach in breast cancer: A review
Panel: Bioinformatics in Cancer
Exploring the Role of TRIB3 in Temozolomide Resistance of Glioblastoma through a ceRNA Regulatory Network Analysis
Panel: Bioinformatics in Cancer
Expression investigation of PD-1, an immune system inhibitory marker, in tumor tissue of bladder cancer patients
Panel: Bioinformatics in Cancer
Expression of lncRNAs DLEU1 and DLEU2 in Ovarian Cancer and Their Association with Clinicopathological Features
Panel: Bioinformatics in Cancer
Fecal extracellular vesicles as emerging mediators in microbiome–host communication and cancer metabolomics: a comprehensive review
Panel: Bioinformatics in Cancer
Feline Mammary Carcinoma – Challenges and Advances in Veterinary Oncology
Panel: Bioinformatics in Cancer
From Bench to Bedside: The Clinical Translation Gap in Cancer Nanomedicine
Panel: Bioinformatics in Cancer
From In Vitro Modeling to Clinical Applications: The Role of 3D Printing in Prostate Cancer Treatment
Panel: Bioinformatics in Cancer
Genetic Alterations in K-RAS, N-RAS, and BRAF Oncogenes in Metastatic Colorectal Cancer: A Frequency Analysis
Panel: Bioinformatics in Cancer
Genomic comparison of feline and human mammary tumors: new insights for cancer modeling.
Panel: Bioinformatics in Cancer
Genomic interventions in oncology: Emerging Strategies to Address Cancer Therapy Limitations
Panel: Bioinformatics in Cancer
Genomic profiling of TMX2 reveals functional variants driving Gliobblastoma
Panel: Bioinformatics in Cancer
Germline Polymorphisms in Chromatin Regulatory Genes Modulate Gut Microbiome and Colorectal Cancer Risk
Panel: Bioinformatics in Cancer
GLS1 Inhibition and Glutamine Addiction in MYC-Driven Burkitt Lymphoma: A Systematic Review
Panel: Bioinformatics in Cancer
Harnessing Oncolytic Viruses for Targeted Treatment of Triple-Negative Breast Cancer: Promises and Challenges
Panel: Bioinformatics in Cancer
Helicobacter pylori and the Role of the Gastric Bacterial Microbiome in Gastric Cancer
Panel: Bioinformatics in Cancer
Histone Dysregulation and Hereditary Cancer Syndromes
Panel: Bioinformatics in Cancer
Identification of Molecular Targets for Gene Therapy in Canine Mammary Tumors Through Integrative Gene Network Analysis
Panel: Bioinformatics in Cancer
Identification of Stage-Specific Genes in Cervical Cancer Using Bioinformatics Tools
Panel: Bioinformatics in Cancer
Immune-Related Genetic Polymorphisms as Predictors of Checkpoint Inhibitor Response in Solid Tumors
Panel: Bioinformatics in Cancer
Impact of Host Genome and Microbiome on Cancer Immunotherapy Response
Panel: Bioinformatics in Cancer
Impact of Lipid Metabolism Reprogramming on Drug Resistance in Breast Cancer: A Systematic Review
Panel: Bioinformatics in Cancer
Integrated Bioinformatics Analysis Identifies CDCA7 and DLGAP5 as Key Genes with NEAT1-Mediated lncRNA Regulation in Chronic-Phase CML
Panel: Bioinformatics in Cancer
Integrating AI/ML and Multi-Omics Approaches in Pancreatic Cancer Research
Panel: Bioinformatics in Cancer
Integration of Systemic Metabolism and Immune Regulation: New Frontiers in Cancer Prevention and Therapy
Panel: Bioinformatics in Cancer
Integrative Bioinformatics Analysis Identifies FYN and Its lncRNA–miRNA Network as Prognostic Biomarkers in Acute Myeloid Leukemia
Panel: Bioinformatics in Cancer
Integrative Bioinformatics to Identify Cell Cycle-Related Prognostic Biomarkers in Triple-Negative Breast Cancer
Panel: Bioinformatics in Cancer
Integrative Multi-Omics Analysis for Personalized Cancer Therapy Combining genomics, proteomics, and metabolomics data from CPTAC or TARGET to design individualized treatments. - Bioinformatic A...
Panel: Bioinformatics in Cancer
Investigating hsa-miR-193-3p and hsa-let-7e-3p and Their Target Genes IGFBP5 and AGPAT5 Associated with Fusobacterium nucleatum in Patients with Colorectal Polyps and CRC: In Silico Predictions and Experimental Validation
Panel: Bioinformatics in Cancer
Investigating the effect of aqueous extract of Centella asiatica plant on the expression of Bax and Bcl-2 genes in rat lung tissue during the process of cancer induction
Panel: Bioinformatics in Cancer
Investigating the interaction between the WNT2 gene as a potential biomarker and its associated miRNA in colorectal cancer through bioinformatics analysis
Panel: Bioinformatics in Cancer
Investigating the Role of the Gut Microbiome in the Response to Melanoma Immunotherapy
Panel: Bioinformatics in Cancer
Investigation of the Association Between HLA (HLA-A, B, DRB1) Alleles and Susceptibility to Acute Lymphoblastic Leukemia in Southern Iran
Panel: Bioinformatics in Cancer
Lactate Dehydrogenase A Overexpression and Tumor Microenvironment Acidosis in Triple-Negative Breast Cancer: A Systematic Review
Panel: Bioinformatics in Cancer
LAT1 Amino Acid Transporter Overexpression and Tumor Growth in Glioblastoma: A Systematic Review
Panel: Bioinformatics in Cancer
Leveraging tumor microenvironment metabolism for smart drug delivery systems
Panel: Bioinformatics in Cancer
Merkel Cell Polyomavirus Large T-Antigen Mutations in Merkel Cell Carcinoma Pathogenesis: A Systematic Review
Panel: Bioinformatics in Cancer
Meta-Analysis on Gene Expression: the Therapeutic Efficacy of Inulin in Caco-2 Cancer Cells
Panel: Bioinformatics in Cancer
Metabolic Interactions in Cancer: A Contemporary Review of TME Crosstalk and Therapeutic Insights
Panel: Bioinformatics in Cancer
Molecular advances in the detection and management of the most common cancer among women over the past three years
Panel: Bioinformatics in Cancer
Municipal Landscape-Derived Echinacea purpurea: A Green Nano-Biotechnological Approach for Enhanced Anticancer Compound Production
Panel: Bioinformatics in Cancer
Network-Based Identification of Molecular Drivers and Therapeutic Targets in Canine Osteosarcoma
Panel: Bioinformatics in Cancer
Next-Generation Cancer Vaccines: mRNA Platforms and Personalized Neoantigen Approaches
Panel: Bioinformatics in Cancer
Oncolytic Herpes Simplex Virus Therapy for Glioblastoma: A Systematic Review of Clinical Outcomes and Immunological Effects
Panel: Bioinformatics in Cancer
Oral Microbiome–Driven Inflammatory Pathways in Head and Neck Squamous Cell Carcinoma: A Systematic Review
Panel: Bioinformatics in Cancer
Physiological Alterations and Gene Regulation in the Tumor Microenvironment
Panel: Bioinformatics in Cancer
Polymorphisms in Tumor Suppressor Genes (TP53, BRCA1/2) and Cancer Risk Modulation
Panel: Bioinformatics in Cancer
Precision CRISPR-Cas9 Targeting of PD-1 in T Cells for Enhanced Immunotherapeutic Response in Solid Tumors : A Systematic Review
Panel: Bioinformatics in Cancer
Progress in Hepatocellular Carcinoma: Transitioning from Molecular Diagnostics to Targeted Treatments and Genomic Insights
Panel: Bioinformatics in Cancer
Reduced KCNA1 Expression Predicts Prognosis and Metastatic Potential in Papillary Thyroid Carcinoma
Panel: Bioinformatics in Cancer
Role of Counseling and Psychological Support in Improving Fertility among Cancer Patients: A Review Study
Panel: Bioinformatics in Cancer
Role of Epigenetically Regulated microRNAs in Gemcitabine Resistance in Pancreatic Cancer
Panel: Bioinformatics in Cancer
Role of non-coding RNAs in the regulation of Urothelial bladder cancer stem-ness
Panel: Bioinformatics in Cancer
Selective Detection of HER3-Positive Breast Cancer Cells Using a Novel Affibody-EGFP Biosensor
Panel: Bioinformatics in Cancer
siRNA-Mediated Knockdown of BUB1 Impairs Growth and Metastatic Potential in Pheochromocytoma Cells
Panel: Bioinformatics in Cancer
Synthetic Lethality Approaches Using Gene Editing for Targeting Cancer Vulnerabilities
Panel: Bioinformatics in Cancer
Systems Biology Approach Reveals ESR1 and CDK1 Regulatory Axis with miRNA–lncRNA Network as Novel Biomarkers in Uterine Corpus Endometrial Carcinoma
Panel: Bioinformatics in Cancer
Targeted Detection of HER3-Expressing Cancer Cells via a Novel Bioluminescent Affibody
Panel: Bioinformatics in Cancer
Targeting Breast Cancer Stem Cells with CAR-T Cells: A Novel Approach
Panel: Bioinformatics in Cancer
The effect of extracellular polysaccharides (EPS) from Lactobacillus casei on advanced liver cancer
Panel: Bioinformatics in Cancer
The gut microbiom and colorectal cancer: a new frontier in aging, inflammation and therapeutic responses
Panel: Bioinformatics in Cancer
The Gut Microbiome as a Determinant of Immunotherapy Response in Metastatic Melanoma
Panel: Bioinformatics in Cancer
The Gut Microbiome's Role in Colorectal Cancer Prognosis and Immunotherapy Response
Panel: Bioinformatics in Cancer
The Gut Microbiome's Role in Modulating PD-1/PD-L1 Immunotherapy Efficacy in Melanoma
Panel: Bioinformatics in Cancer
The Human Microbiome in Cancer: Mechanisms, Biomarkers, and Therapeutic Potentials
Panel: Bioinformatics in Cancer
The impact of the gut microbiome on the effectiveness of cancer immunotherapy
Panel: Bioinformatics in Cancer
The interaction of lncRNA and mRNA in Esophageal Squamous Cell Carcinoma
Panel: Bioinformatics in Cancer
The Interplay of HPV Oncoproteins, Tumor Microenvironment, and Extracellular Vesicles in Cervical Cancer Progression
Panel: Bioinformatics in Cancer
The Role of Epigenetics in the Prevention and Treatment of Hereditary Colorectal Cancer through Nutrition and Targeted Therapies.
Panel: Bioinformatics in Cancer
The Role of Gut Microbiome in Colorectal Cancer
Panel: Bioinformatics in Cancer
The Role of SCFAs Derived from Gut Microbiota in Colorectal Cancer Progression; A Systematic Overview
Panel: Bioinformatics in Cancer
The Role of the Human Microbiome in Cancer Development and Therapy Response
Panel: Bioinformatics in Cancer
The Role of the Microbiome in Cancer Prevention and Therapy
Panel: Bioinformatics in Cancer
The Role of the Urinary Microbiome in Prostate Cancer Progression: From Early Detection to Targeted Therapy
Panel: Bioinformatics in Cancer
The suppressive role of the bone marrow microenvironment on natural killer cells’ anti-leukemic activity in acute myeloid leukemia
Panel: Bioinformatics in Cancer
The Tumor Microenvironment and Immunotherapy Response: Challenges and Opportunities in Precision Oncology
Panel: Bioinformatics in Cancer
The Warburg Effect and Cancer Progression: Glycolytic Reprogramming, Epigenetic Modifications, and Therapeutic Perspectives
Panel: Bioinformatics in Cancer
Thermostabilization and Structural Optimization of Cas9 Variants Using Protein Stability Predictions and AlphaFold Modeling
Panel: Bioinformatics in Cancer
Unraveling the Role of FGFR3 in Melanoma Progression: An Integrated Bioinformatics Approach to mRNA Expression and ceRNA Network Analysis.
Panel: Bioinformatics in Cancer
Unveiling Molecular Mechanisms and Biomarkers for Colitis-Associated Colorectal Cancer in Ulcerative Colitis
Panel: Bioinformatics in Cancer
Using Three Machine Learning Techniques for Predicting Breast Cancer Recurrence
Panel: Bioinformatics in Cancer
Utilizing WGCNA to uncover E2F8 and SPC24 as promising therapeutic targets in breast cancer
Panel: Bioinformatics in Cancer
Wnt/β-catenin Signaling Pathway Mediated by the Gut Microbiome: The Influence of Fusobacterium nucleatum on Colorectal Cancer Progression
Panel: Bioinformatics in Cancer
